In summary, our studies have demonstrated that both CPH and ENT exhibit anti-tumor activity by enhancing NK cell-mediated cellular cytotoxicity in UC cell lines and syngeneic tumor mouse models. This evidence concerns the gene NT5E and neoplasm.